Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Yumiko Sujino"'
Autor:
Huijia Guo, Kazutaka Nishina, Rintaro Iwata Hara, Wenying Piao, Takanori Yokota, Kie Yoshida-Tanaka, Taiki Kunieda, Satoshi Obika, Takeshi Wada, Kotaro Yoshioka, Haruka Miyata, Tetsuya Nagata, Yumiko Sujino, Hiroya Kuwahara, Yutaro Asami
Publikováno v:
Nucleic Acids Research
AntimiR is an antisense oligonucleotide that has been developed to silence microRNA (miRNA) for the treatment of intractable diseases. Enhancement of its in vivo efficacy and improvement of its toxicity are highly desirable but remain challenging. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63779beb3b177aacfba47d66ad0c9d62
http://europepmc.org/articles/PMC6698647
http://europepmc.org/articles/PMC6698647
Autor:
Wenying Piao, Takanori Yokota, Hiroya Kuwahara, Satoshi Obika, Masayuki Yoshida, Tsuyoshi Yamamoto, Koichi Miyake, Punit P. Seth, Kie Yoshida-Tanaka, C. Frank Bennett, Kazunori Kataoka, Hidehiro Mizusawa, Tomoko Nishina, Takeshi Baba, Kanjiro Miyata, Keiko Nitta, Fumiko Ono, Audrey Low, Kotaro Yoshioka, Yumiko Sujino, Kazutaka Nishina, Hidenori Yasuhara
Publikováno v:
Nature Communications
Antisense oligonucleotides (ASOs) are recognized therapeutic agents for the modulation of specific genes at the post-transcriptional level. Similar to any medical drugs, there are opportunities to improve their efficacy and safety. Here we develop a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2089a8502a0c92ec72d362448a2a3a65
https://doi.org/10.1038/ncomms8969
https://doi.org/10.1038/ncomms8969